Granulocyte colony-stimulating factor (G-CSF) is a cytokine best known for its role in driving the proliferation, differentiation and survival of neutrophil precursors. Within malignant tissues, ...

Value-based programs, such as the Oncology Care Model (OCM), seek to improve care for patients undergoing chemotherapy, while reducing total costs. The purpose of this study is to quantify the impact ...

The immune impact of G-CSF on the repertoire and function of T cells have been explored previously. Earlier studies had demonstrated the impact of G-CSF–mobilized allografts on altering T-cell ...

Stroke remains a leading cause of morbidity worldwide, with limited pharmacological options beyond thrombolysis and thrombectomy in the acute phase. Granulocyte colony-stimulating factor (G-CSF), a ...

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

The effects of sargramostim and filgrastim on hematopoietic cells are described. Filgrastim is a lineage-specific colonystimulating factor (CSF), mainly affecting neutrophils. In addition to enhancing ...

Please provide your email address to receive an email when new articles are posted on . In certain settings. Whether a patient has cancer or not, we are trained to reach into our toolbox for whatever ...

Limitations and other factors to consider when utilizing granulocyte colony-stimulating factors as prophylaxis for chemotherapy-induced neutropenia. Lee Schwartzberg, MD, FACP: While ...

We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines. Objective: To examine ...